Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
APPLIED MATERIALS INC /DE
Report date April 06, 2015 · Filed April 06, 2015
Section 16 reporting ended · disclosed 2015-04-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,958.178 |
Reported balance
Holding disclosure · report date 2015-04-06 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 144,958.178 F1: Includes shares converted from previously vested restricted stock units ("RSUs") that Mr. Rogers had elected to defer, and that were paid to Mr. Rogers upon his termination of service as a member of the Applied Board on April 2, 2015, as well as shares from accrued dividends paid on such previously vested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares converted from previously vested restricted stock units ("RSUs") that Mr. Rogers had elected to defer, and that were paid to Mr. Rogers upon his termination of service as a member of the Applied Board on April 2, 2015, as well as shares from accrued dividends paid on such previously vested RSUs.
Cigna Holding Co
Report date December 20, 2018 · Filed December 26, 2018
Section 16 reporting ended · disclosed 2018-12-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.25 Par ValueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 1
1 source rowRow 1 · 2018-12-20 · Disposition to issuer · Disposed 38,453 · Balance 0 F1: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-12-20 · Disposition to issuer · Disposed 11,896 · Balance 0 F3: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. F1: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote)
F2: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30.
F3: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2018 Filed Dec 26, 2018 18:45 UTC | Cigna Holding Co CI · Entity 161580 | Disposition to issuerPhantom Stock Units · Derivative | 11,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-18-008659 · doc1.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.25 Par Value · 11,896 shares Expires not disclosed F3 · security: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. F3 · derivative.exercise_price: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. F1 · kind: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. F3 · kind: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. F1 · price: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. F3 · price: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. F3 · derivative.exercise_date: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. F3 · derivative.expiration_date: The phantom stock units described in Table II are credited under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation. Each phantom stock unit of Cigna is the economic equivalent of one share of Cigna Common Stock that would have been settled in cash. Under the Merger Agreement, each phantom stock unit of Cigna was exchanged for one phantom stock unit of New Cigna, which is the economic equivalent of one share of New Cigna Common Stock and will be settled in cash. Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 18:45 UTC | Cigna Holding Co CI · Entity 161580 | Disposition to issuerCommon Stock, $.25 Par Value | 38,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-008659 · doc1.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · kind: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. F1 · price: Reflects disposition in connection with the consummation of the mergers (collectively, the "Merger") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) ("Cigna"), Express Scripts Holding Company ("Express Scripts"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger ("New Cigna"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the "Merger Agreement"), pursuant to which, at the effective time of the Merger (the "Effective Time"), (continued in following footnote) F2 · price: (continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share ("Cigna Common Stock"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna ("New Cigna Common Stock"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 18:28 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 128 | $223.38 | $28,592.64 |
DisclosureSEC source: 0001225208-18-016225 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,896 Underlying: Common Stock, $.25 Par Value · 128 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 18:28 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-016225 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,453 Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 17:50 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 152 | $188.34 | $28,627.68 |
DisclosureSEC source: 0001225208-18-013188 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,768 Underlying: Common Stock, $.25 Par Value · 152 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 17:50 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-013188 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,252 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 17:27 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 170 | $169.37 | $28,792.90 |
DisclosureSEC source: 0001225208-18-010118 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,616 Underlying: Common Stock, $.25 Par Value · 170 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F2 · balance_after: Includes 1 phantom stock unit acquired pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Directors of Cigna Corporation. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 17:27 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-010118 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,014 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 17:25 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 146 | $195.89 | $28,599.94 |
DisclosureSEC source: 0001225208-18-005164 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,445 Underlying: Common Stock, $.25 Par Value · 146 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 17:25 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 229 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-005164 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,749 Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 18:05 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 136 | $211.73 | $28,795.28 |
DisclosureSEC source: 0001225208-17-018130 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,299 Underlying: Common Stock, $.25 Par Value · 136 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 18:05 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018130 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,520 Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 17:07 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 158 | $182.06 | $28,765.48 |
DisclosureSEC source: 0001225208-17-014585 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,163 Underlying: Common Stock, $.25 Par Value · 158 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 17:07 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014585 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,308 Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 18:32 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 178 | $161.23 | $28,698.94 |
DisclosureSEC source: 0001225208-17-010850 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,005 Underlying: Common Stock, $.25 Par Value · 178 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F2 · balance_after: Includes 3 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Directors of Cigna Corporation. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 18:32 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 279 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-010850 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,061 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 17:48 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 192 | $148.90 | $28,588.80 |
DisclosureSEC source: 0001225208-17-005385 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,824 Underlying: Common Stock, $.25 Par Value · 192 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 17:48 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-005385 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,782 Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 17:12 UTC | Cigna Holding Co CI · Entity 161580 | GrantPhantom Stock Units · Derivative | 176 | $134.74 | $23,714.24 |
DisclosureSEC source: 0001225208-16-042629 · doc4.xml · derivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,632 Underlying: Common Stock, $.25 Par Value · 176 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 17:12 UTC | Cigna Holding Co CI · Entity 161580 | GrantCommon Stock, $.25 Par Value | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-042629 · doc4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,480 Read SEC document |
| March 04, 2014 Filed Mar 7, 2014 00:17 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 10,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-010617 · form4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,391.178 F1 · shares: Represents automatic annual grant of restricted stock units to non-employee member of the Board of Directors pursuant to the Applied Materials, Inc. ("Applied") Employee Stock Incentive Plan. These restricted stock units will be converted on a one-for-one basis into shares of Applied common stock upon vesting, which vesting is scheduled to occur on March 1, 2015 (subject to accelerated vesting as of three trading days prior to the closing of the transactions contemplated in connection with the business combination agreement, dated September 24, 2013, between Applied and Tokyo Electron Limited, as amended, and continued service as a director through the vest date). F2 · balance_after: Number of shares includes 81,845 restricted stock units previously reported, of which (a) 78,678 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board and (b) 3,167 units are scheduled to vest in March 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (subject to accelerated vesting described in footnote 1 and continued service as a director through the vest date). Read SEC document |
| March 05, 2013 Filed Mar 8, 2013 00:54 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 14,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-010004 · form4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,776.178 F1 · shares: Represents automatic annual grant of restricted stock units to non-employee member of the Board of Directors (the "Board") pursuant to the Applied Materials, Inc. ("Applied") Employee Stock Incentive Plan. These restricted stock units are scheduled to vest on March 1, 2014 (subject to continued service as a director through the vest date). Pursuant to Mr. Rogers' election to defer, any units that vest from this grant will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board. F2 · balance_after: Number of shares includes 67,289 restricted stock units previously reported, of which (a) 56,887 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board and (b) 10,402 units are scheduled to vest in installments during each March of 2014 and 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each applicable vest date). Read SEC document |
| September 13, 2012 Filed Dec 8, 2012 02:30 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | PurchaseCommon Stock | 375.143 | $11.65 | $4,370.42 |
DisclosureSEC source: 0001127602-12-033215 · form4.xml · nonDerivative · entry 6 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,220.178 F1 · shares: Represents number of shares acquired under a broker-administered dividend reinvestment program that automatically reinvested dividends paid on Applied Materials, Inc. ("Applied") common stock. F4 · balance_after: Number of shares includes 67,289 restricted stock units previously reported, of which (a) 27,570 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board; and (b) 39,719 units are scheduled to vest in installments during each March of 2013 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| June 14, 2012 Filed Dec 8, 2012 02:30 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | PurchaseCommon Stock | 399.602 | $10.85 | $4,335.68 |
DisclosureSEC source: 0001127602-12-033215 · form4.xml · nonDerivative · entry 5 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,845.035 F1 · shares: Represents number of shares acquired under a broker-administered dividend reinvestment program that automatically reinvested dividends paid on Applied Materials, Inc. ("Applied") common stock. F4 · balance_after: Number of shares includes 67,289 restricted stock units previously reported, of which (a) 27,570 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board; and (b) 39,719 units are scheduled to vest in installments during each March of 2013 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| March 15, 2012 Filed Dec 8, 2012 02:30 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | PurchaseCommon Stock | 271.296 | $12.65 | $3,431.89 |
DisclosureSEC source: 0001127602-12-033215 · form4.xml · nonDerivative · entry 4 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,445.433 F1 · shares: Represents number of shares acquired under a broker-administered dividend reinvestment program that automatically reinvested dividends paid on Applied Materials, Inc. ("Applied") common stock. F3 · balance_after: Number of shares includes 72,289 restricted stock units previously reported, of which (a) 27,570 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board; (b) 5,000 units are scheduled to vest in April 2012, and (c) 39,719 units are scheduled to vest in installments during each March of 2013 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 00:19 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 16,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-010220 · form4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,289 F1 · shares: Represents automatic annual grant of restricted stock units to non-employee member of the Board of Directors (the "Board") pursuant to the Applied Materials, Inc. ("Applied") Employee Stock Incentive Plan. These restricted stock units are scheduled to vest on March 1, 2013 (subject to continued service as a director through the vest date). Pursuant to Mr. Rogers' election to defer, any units that vest from this grant will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board. F2 · balance_after: Number of shares includes 55,630 restricted stock previously reported, of which (a) 27,570 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board, (b) 5,000 units will be converted in the future on a one-for-one basis into shares of Applied common stock upon vesting, which vesting is scheduled to occur in April 2012, and (c) 23,060 units are scheduled to vest in installments during each March of 2013 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| March 06, 2012 Filed Dec 8, 2012 02:29 UTC Amendment | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 16,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-033214 · form4a.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,174.137 F1 · shares: Represents automatic annual grant of restricted stock units to non-employee member of the Board of Directors (the "Board") pursuant to the Applied Materials, Inc. ("Applied") Employee Stock Incentive Plan. These restricted stock units are scheduled to vest on March 1, 2013 (subject to continued service as a director through the vest date). Pursuant to Mr. Rogers' election to defer, any units that vest from this grant will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board. F2 · balance_after: Number of shares has been increased in this amended Form 4 to reflect the fact that 115,174.137 shares (not 114,289 shares) should have been reported as held by Mr. Rogers on his Form 4 filed March 8, 2012. The additional 885.137 shares were acquired by Mr. Rogers before March 6, 2012 pursuant to a broker-administered dividend reinvestment program but were not reported prior to that date. Number of shares includes 55,630 restricted stock units previously reported, of which (a) 27,570 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board, (b) 5,000 units will be converted in the future on a one-for-one basis into shares of Applied common stock upon vesting, which vesting is scheduled to occur in April 2012, and (c) 23,060 units are scheduled to vest in installments during each March of 2013 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| December 14, 2011 Filed Dec 8, 2012 02:30 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | PurchaseCommon Stock | 320.996 | $10.61 | $3,405.77 |
DisclosureSEC source: 0001127602-12-033215 · form4.xml · nonDerivative · entry 3 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,515.137 F1 · shares: Represents number of shares acquired under a broker-administered dividend reinvestment program that automatically reinvested dividends paid on Applied Materials, Inc. ("Applied") common stock. F2 · balance_after: Number of shares includes 55,630 restricted stock units previously reported, of which (a) 14,913 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board of Directors (the "Board"); (b) 5,000 units are scheduled to vest in April 2012, and (c) 35,717 units are scheduled to vest in installments during each March of 2012 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| September 21, 2011 Filed Dec 8, 2012 02:30 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | PurchaseCommon Stock | 298.486 | $11.33 | $3,381.85 |
DisclosureSEC source: 0001127602-12-033215 · form4.xml · nonDerivative · entry 2 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,194.141 F1 · shares: Represents number of shares acquired under a broker-administered dividend reinvestment program that automatically reinvested dividends paid on Applied Materials, Inc. ("Applied") common stock. F2 · balance_after: Number of shares includes 55,630 restricted stock units previously reported, of which (a) 14,913 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board of Directors (the "Board"); (b) 5,000 units are scheduled to vest in April 2012, and (c) 35,717 units are scheduled to vest in installments during each March of 2012 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| June 22, 2011 Filed Dec 8, 2012 02:30 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | PurchaseCommon Stock | 265.655 | $12.65 | $3,360.54 |
DisclosureSEC source: 0001127602-12-033215 · form4.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,895.655 F1 · shares: Represents number of shares acquired under a broker-administered dividend reinvestment program that automatically reinvested dividends paid on Applied Materials, Inc. ("Applied") common stock. F2 · balance_after: Number of shares includes 55,630 restricted stock units previously reported, of which (a) 14,913 units have vested and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service as a member of the Applied Board of Directors (the "Board"); (b) 5,000 units are scheduled to vest in April 2012, and (c) 35,717 units are scheduled to vest in installments during each March of 2012 through 2015 and which, pursuant to Mr. Rogers' election to defer, will be converted on a one-for-one basis into shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| March 08, 2011 Filed Mar 11, 2011 01:42 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 12,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-11-017226 · rrd304928.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,630 F1 · shares: Represents automatic annual grant of performance shares (restricted stock units) to non-employee member of the Board of Directors (the "Board") pursuant to the Applied Materials, Inc. ("Applied") Employee Stock Incentive Plan. These performance shares are scheduled to vest in four equal annual installments beginning 3/1/2012 (subject to continued service as a director through each vest date). Pursuant to Mr. Rogers' election, any shares that vest from this grant will be converted to shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board. F2 · balance_after: Number of shares includes: (a) 14,913 performance shares (restricted stock units) that previously vested and which, pursuant to Mr. Rogers' election, will be converted to shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board; and (b) 33,051 performance shares (restricted stock units) previously reported that in the future will be converted on a one-for-one basis into shares of Applied common stock upon vesting, which vesting is scheduled to occur as follows: (i) 10,000 shares are scheduled to vest in installments during each April of 2011 and 2012, and (ii) 23,051 shares are scheduled to vest in installments during each March of 2012 through 2014 and which, pursuant to Mr. Rogers' election, will be converted to shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| March 09, 2010 Filed Mar 12, 2010 02:05 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 16,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-10-015837 · rrd269538.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,964 F1 · shares: Represents automatic annual grant of performance shares (restricted stock units) to non-employee member of the Board of Directors (the "Board") pursuant to the Applied Materials, Inc. ("Applied") Employee Stock Incentive Plan. These performance shares are scheduled to vest in four equal annual installments beginning 3/1/11 (subject to continued service as a director through each vest date). Pursuant to Mr. Rogers' election, any shares that vest from this grant will be converted to shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board. F2 · balance_after: Number of shares includes: (a) 5,422 performance shares that previously vested and which, pursuant to Mr. Rogers' election, will be converted to shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board; and (b) 31,269 performance shares (restricted stock units) previously reported, of which (i) 15,000 shares will be converted in the future on a one-for-one basis into shares of Applied common stock upon vesting, which vesting is scheduled to occur in three equal installments beginning 4/27/10 and (ii) 16,269 shares are scheduled to vest in three equal annual installments beginning 3/1/11 and, pursuant to Mr. Rogers' election, will be converted to shares of Applied common stock and paid to him on the date of his termination of service from the Applied Board (all vesting is subject to continued service as a director through each vest date). Read SEC document |
| May 14, 2009 Filed May 19, 2009 01:16 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | PurchaseCommon Stock | 27,000 | $11.25 | $303,685.20 |
DisclosureSEC source: 0001181431-09-025588 · rrd242862.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,691 F1 · balance_after: Number of shares includes 36,691 performance shares (or restricted stock units) previously reported that in the future will be converted on a one-for-one basis into shares of Applied Materials, Inc. common stock upon vesting, which vesting is scheduled to occur as follows: (a) 15,000 performance shares are scheduled to vest in three equal installments beginning 4/27/10 and (b) 21,691 performance shares are scheduled to vest in four equal annual installments beginning 3/1/10 (all vesting is subject to continued service as a director). Read SEC document |
| March 10, 2009 Filed Mar 13, 2009 01:45 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 21,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-09-015439 · rrd237233.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,691 F1 · shares: Represents automatic annual grant of performance shares (restricted stock units) to non-employee member of the Board of Directors pursuant to the Applied Materials, Inc. Employee Stock Incentive Plan. These performance shares will be converted on a one-for-one basis into shares of Applied Materials, Inc. common stock immediately upon vesting, which vesting is scheduled to occur in four equal annual installments beginning 3/1/10 (subject to continued service as a director). F2 · balance_after: Number of shares includes 20,000 performance shares (or restricted stock units) previously reported that in the future will be converted on a one-for-one basis into shares of Applied Materials, Inc. common stock upon vesting, which vesting is scheduled to occur in four equal installments beginning 4/27/09 (subject to continued service as a director). Read SEC document |
| April 27, 2008 Filed Apr 30, 2008 00:17 UTC | APPLIED MATERIALS INC /DE AMAT · Entity 2812 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-027364 · rrd204262.xml · nonDerivative · entry 1 ROGERS JAMES E · CIK 0001024251 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Represents automatic initial grant of performance shares (or restricted stock units) to non-employee director upon appointment to the Board of Directors pursuant to the Applied Materials, Inc. Employee Stock Incentive Plan. These performance shares will be converted on a one-for-one basis into Applied Materials, Inc. common stock upon vesting, which vesting is scheduled to occur in four equal annual installments beginning 4/27/09 (subject to continued service as a director). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.